|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.80 USD | -0.92% |
|
-0.65% | +34.34% |
| 05-12 | Celanese Shares Rise After JPMorgan Upgrade | MT |
| 05-12 | JPMorgan Upgrades Celanese to Overweight From Neutral, Price Target is $68 | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 8.54B | 9.67B | 10.94B | 10.28B | 9.54B | |||||
Total Revenues | 8.54B | 9.67B | 10.94B | 10.28B | 9.54B | |||||
Cost of Goods Sold, Total | 5.86B | 7.29B | 8.34B | 7.85B | 7.58B | |||||
Gross Profit | 2.68B | 2.38B | 2.6B | 2.43B | 1.96B | |||||
Selling General & Admin Expenses, Total | 527M | 690M | 1.14B | 1.05B | 844M | |||||
R&D Expenses | 86M | 112M | 146M | 130M | 125M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 25M | 62M | 164M | 159M | 164M | |||||
Other Operating Expenses | - | - | - | - | - | |||||
Other Operating Expenses, Total | 638M | 864M | 1.45B | 1.34B | 1.13B | |||||
Operating Income | 2.04B | 1.52B | 1.15B | 1.09B | 830M | |||||
Interest Expense, Total | -91M | -405M | -720M | -676M | -701M | |||||
Interest And Investment Income | 155M | 202M | 165M | 161M | 146M | |||||
Net Interest Expenses | 64M | -203M | -555M | -515M | -555M | |||||
Income (Loss) On Equity Invest. | 146M | 220M | 102M | 196M | 127M | |||||
Currency Exchange Gains (Loss) | 2M | -2M | -19M | -26M | 36M | |||||
Other Non Operating Income (Expenses) | -5M | 10M | 76M | 90M | 7M | |||||
EBT, Excl. Unusual Items | 2.25B | 1.54B | 753M | 833M | 445M | |||||
Restructuring Charges | 5M | 6M | -53M | -176M | -79M | |||||
Merger & Related Restructuring Charges | - | -117M | - | - | - | |||||
Impairment of Goodwill | - | - | - | - | -1.14B | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | 3M | 5M | 505M | -14M | -5M | |||||
Asset Writedown | -2M | -14M | -15M | -1.64B | -373M | |||||
Legal Settlements | - | - | - | - | - | |||||
Other Unusual Items | -9M | - | -7M | - | -68M | |||||
EBT, Incl. Unusual Items | 2.25B | 1.42B | 1.18B | -996M | -1.22B | |||||
Income Tax Expense | 330M | -489M | -790M | 510M | -90M | |||||
Earnings From Continuing Operations | 1.92B | 1.91B | 1.97B | -1.51B | -1.13B | |||||
Earnings Of Discontinued Operations | -22M | -8M | -9M | -8M | -21M | |||||
Net Income to Company | 1.9B | 1.9B | 1.96B | -1.51B | -1.15B | |||||
Minority Interest | -6M | -8M | -4M | -8M | -14M | |||||
Net Income - (IS) | 1.89B | 1.89B | 1.96B | -1.52B | -1.16B | |||||
Net Income to Common Incl Extra Items | 1.89B | 1.89B | 1.96B | -1.52B | -1.16B | |||||
Net Income to Common Excl. Extra Items | 1.91B | 1.9B | 1.97B | -1.51B | -1.14B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 16.99 | 17.48 | 18.01 | -13.93 | -10.64 | |||||
Basic EPS - Continuing Operations | 17.19 | 17.55 | 18.09 | -13.86 | -10.44 | |||||
Basic Weighted Average Shares Outstanding | 111M | 108M | 109M | 109M | 110M | |||||
Net EPS - Diluted | 16.86 | 17.34 | 17.92 | -13.93 | -10.64 | |||||
Diluted EPS - Continuing Operations | 17.06 | 17.41 | 18 | -13.86 | -10.44 | |||||
Diluted Weighted Average Shares Outstanding | 112M | 109M | 109M | 109M | 110M | |||||
Normalized Basic EPS | 12.6 | 8.81 | 4.29 | 4.69 | 2.41 | |||||
Normalized Diluted EPS | 12.5 | 8.74 | 4.27 | 4.69 | 2.41 | |||||
Dividend Per Share | 2.72 | 2.74 | 2.8 | 2.8 | 0.12 | |||||
Payout Ratio | 16.08 | 15.68 | 15.56 | -20.17 | -1.12 | |||||
American Depositary Receipts Ratio (ADR) | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |||||
Supplemental Items | ||||||||||
EBITDA | 2.42B | 1.98B | 1.83B | 1.8B | 1.56B | |||||
EBITA | 2.07B | 1.57B | 1.27B | 1.2B | 952M | |||||
EBIT | 2.04B | 1.52B | 1.15B | 1.09B | 830M | |||||
EBITDAR | 2.49B | 2.07B | 1.96B | 1.93B | 1.69B | |||||
Effective Tax Rate - (Ratio) | 14.68 | -34.41 | -66.78 | -51.2 | 7.38 | |||||
Current Domestic Taxes | - | 54M | 8M | 79M | 3M | |||||
Current Foreign Taxes | 323M | 306M | 162M | 239M | 158M | |||||
Total Current Taxes | 323M | 360M | 170M | 318M | 161M | |||||
Deferred Domestic Taxes | -16M | -261M | -178M | -87M | -107M | |||||
Deferred Foreign Taxes | 23M | -588M | -782M | 279M | -144M | |||||
Total Deferred Taxes | 7M | -849M | -960M | 192M | -251M | |||||
Normalized Net Income | 1.4B | 955M | 467M | 513M | 264M | |||||
Interest Capitalized | 12M | 18M | 37M | 30M | 24M | |||||
Interest on Long-Term Debt | 34M | 29M | 54M | 38M | 99M | |||||
Non-Cash Pension Expense | -101M | -8M | 64M | 22M | -58M | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 89M | 121M | 189M | 172M | 167M | |||||
Net Rental Expense, Total | 70M | 98M | 131M | 134M | 124M | |||||
Imputed Operating Lease Interest Expense | 13.98M | 34.31M | 54.29M | 55.96M | 55.57M | |||||
Imputed Operating Lease Depreciation | 56.02M | 63.69M | 76.71M | 78.04M | 68.43M | |||||
Stock-Based Comp., Other (Total) | 95M | 60M | 40M | 32M | 24M | |||||
Total Stock-Based Compensation | 95M | 60M | 40M | 32M | 24M |
- Stock Market
- Equities
- CE Stock
- Financials Celanese Corporation
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















